Case Report | Open Access
Giorgio Berlot, Rossana Bussani, Vennus Shafiei, Nadia Zarrillo, "Fulminant Cerebral Fat Embolism: Case Description and Review of the Literature", Case Reports in Critical Care, vol. 2018, Article ID 7813175, 5 pages, 2018. https://doi.org/10.1155/2018/7813175
Fulminant Cerebral Fat Embolism: Case Description and Review of the Literature
The release of fat and bone marrow fragments is a common occurrence following traumatic and nontraumatic events. In most cases, they go symptomless or cause only minor disturbances, but occasionally they can determine a multiorgan dysfunction whose severity ranges from mild to fatal. The authors describe the case of a patient who became deeply comatose and ultimately died after a traffic accident in which he suffered the exposed right femoral and tibial fracture in the absence of other injuries. He underwent the external fixation of the fractured bones 2 hours after the admission under general anesthesia. Three hours later, he failed to awake at the suspension of the anesthetic agents and became anisocoric; a CT scan demonstrated a diffuse cerebral edema with the herniation of the cerebellar tonsils; these abnormalities were unresponsive to the treatment and the brain death was one day later. The causes, the mechanisms, the symptoms, the prevention, and the treatment of the syndrome are reviewed and discussed.
A number of traumatic as well nontraumatic circumstances can determine the passage of bone components such as fat and hemopoietic tissue into the bloodstream [1–3]. Independently from the triggering event, the ensuing fat and bone marrow emboli (FE and BME, respectively) can reach the systemic circulation crossing the lung capillaries, through intrapulmonary physiologic shunts or via a patent foramen ovale (PFO) .
In most cases, FE and BME cause no or only minor clinical consequences and only few patients develop systemic complications, a condition usually known as Fat Embolism Syndrome (FES). However, despite its widespread use, this denomination ignores the relevant role played by the BME especially in younger subjects. Whatever acronym is used, two different and not mutually exclusive mechanisms have been hypothesized in its pathogenesis: the first consists in the obstruction of the microvascular network by one or both components (mechanical hypothesis) whereas the other advocates the irritative effects exerted by the free fatty acids released by the interaction between the FE and the lung lipases on the endothelium and the subsequent activation of the inflammatory and coagulative cascades (biochemical hypothesis) .
The subsequent dysfunction(s) and related symptoms can occur alone or in combination and are primarily related to the end organ(s) involved. The most common clinical presentations include a noncardiogenic pulmonary edema, disturbances of the central nervous system (CNS) of variable severity, and coagulative alterations. Remarkably, despite the high number of predisposing circumstances, the occurrence of a full-blown FES is reported only occasionally [5, 6]. In the absence of a specific treatment, the early fixation of long-bone fractures and the avoidance of the intramedullary reaming represents the only measures that are able to prevent the syndrome and/or to reduce the related complications [6, 7].
Here we describe the case of a trauma patient who developed a fulminant cerebral FES approximately two hours after the trauma when he underwent urgent orthopaedic surgery under general anesthesia.
2. Case Description
A 17-year-old man was involved in a road accident in which he suffered the open fractures of the right femur and tibia. At the arrival to the Emergency Dept (ED), he was alert and hemodynamically stable and the Glasgow Coma Scale (GCS) was 15; the initial alignment of the fractured ends was performed in the ED with a gentle traction performed under sedation with iv. ketamine; a total body CT did not demonstrate other injuries. Approximately two hours after the admission the patient was taken to the surgical theatre for the external fixation of the fractured bones; at entering the operating room, the GCS was 8, the arterial pressure was 115/80 mm Hg, the heart rate was 115 bpm, and the arterial oxygen saturation (SPO2) was 85 at room air; the procedure was performed under general iv anesthesia with propofol and remifentanyl; the standard monitoring included the ECG, the noninvasive arterial pressure, the SPO2, and the end-tidal CO2 (ETCO2); during the intervention, the SPO2 rose to 100% at a FIO2=40% and all the other variables remained stable throughout the procedure after the 3-hour-long intervention in which the complete alignment of the bony ends was achieved; the patient was transferred to the Intensive Care Unit (ICU) still intubated and mechanically ventilated; the iv anaesthetics were gradually tapered until the complete suspension. Two hours later, the SpaO2 and the ETCO2 slightly decreased and anisocoria was observed; and an urgent CT scan of the head demonstrated a diffuse cerebral edema and the herniation of the cerebellar tonsils (Figures 1(a) and 1(b), respectively). At this time, the pupils became bilaterally mydriatic and the EEG was almost isoelectric; due to the severity of the conditions, a MR scan was considered unnecessary. On the basis of the clinical and radiologic findings repeated boluses of iv. mannitol and steroids were given in the following hours aiming to reduce the intracranial pressure. An echocardiogram demonstrated a severe right ventricular depression with an ejection fraction of 20%. On the following day, the patient was declared brain dead according to the current Italian law.
At the autopsy, the cerebral microvascular network appeared diffusely plugged with BME (Figures 2–4) and ischemia-related microcalcifications were scattered throughout the brain (Figure 5); other organs were less extensively involved; no PFO was demonstrated.
In trauma patients, the diagnosis of FES can be challenging because the symptoms (a) are not specific, ranging from mild dyspnoea to severe disturbances of the central nervous system (CNS) and possibly death; (b) appear after variable intervals of time after the injury; and, finally, (c) can overlap with those caused by the initiating event. Then, it is likely that this clinical entity goes largely undiagnosed either in adult or in pediatric patients [11–13] as reflected also by the wide variations of its incidence and time of onset reported in different studies, ranging from ≤ 1% to 35% and from ≤ 6 to > 48 hours, respectively [2, 14].
Once triggered, the outcome of patients with FES is related to different circumstances, including the amount of BME and FE released, their final location, and the severity of the end organ dysfunction. The fulminant clinical course and the poor outcome of our patient despite the immediate external fixation, which is considered the gold standard for patients at risk, deserve some remarks. [15, 16].
First, the double long-bone fracture likely determined a massive release of FE and BME. Actually, both their amount and the velocity of bloodstream invasion have been associated with the outcome: Kamenar et al.  observed up to 100 fat globules /mm2 of brain area in an autoptical study performed in a patient with a femoral shaft fracture and Cui et al.  demonstrated that the velocity of infusion of BM-derived mesenchymal stem-cells as well as their dose was positively associated with the appearance of cerebral ischemic lesions in a rodent model of cell-based therapy for stroke. More recently, also Jarmer et al.  observed a correlation between the severity of the fractures, the amount of pulmonary FE, and the outcome. As occurred in our patient, FE and BME can get the systemic circulation via pathways other than a PFO, including the lung microvascular network and the intrapulmonary physiologic shunts.
Second, it is likely that the embolic spread towards the brain initiated immediately after the trauma and continued during both the initial stabilization and the intervention due to the manipulations of the fractured bone ends; the progressive ischemic and cytotoxic damage to the lung and the brain caused by the FE and  likely account for the deterioration of the SPO2 and of the neurologic conditions observed at the arrival in the surgical theatre. Actually, it appears that both the severity and the timing of the initial CNS symptoms are related to the outcome: in a recent review, Kellogg et al.  reported that no or only minor mental status changes, focal deficits, or seizures at the admission were associated with a good outcome in 90,6% of patients, but this rate dropped to 57,6% in the presence of coma or abnormal posturing; other investigators demonstrated that the duration of the free interval is associated with the outcome, being worse in patients whose symptoms were present already in an earlier phase (1-8 hours) as compared with those whose neurological deterioration appeared later on [14, 19]. As far as the imaging is concerned, the CT scan is considered not sensible enough especially in the initial phases of the disease and a MR scan is warranted in order to detect the scattered (so-called “starfield pattern”) or confluent areas of cytotoxic edema caused by the plugging of the cerebral vascular network . This imaging was not obtained in our patient due to the absence of any therapeutic option other than the administration of mannitol and steroids able to reverse or limit the already established severe neurologic damage.
Third, both the SPO2 and the ETCO2 did not change during the surgical procedure, possibly due to the better cardiopulmonary functional reserves of a young subject, and started to deteriorate only after the ICU admission. Actually, the lack of specific signs and symptoms directly ascribable to BME of FE makes the diagnosis elusive and a number of scoring systems have been developed to overcome these difficulties (Table 1) [4, 8, 9, 20]; however, all of them require, among other signs, a deterioration of gas exchanges in association with acute changes in CNS function; yet, we could not observe alterations of these due to the general anesthesia and mechanical ventilation.
Fourth, the presence of BME is far less common that that of FE: actually, Dettmer et al.  studied a group of 982 patients (age 75,7±11,9 years) who died following trauma and orthopaedic procedures and observed that (a) a BE or a FE was present in only 34 (3,4%) cases; (b) a BME was present in only 3% of them; and (c) they were mutually exclusive, the BE being primarily associated with the resuscitative manoeuvres and the FE with orthopaedic procedures and/or bone disease; this finding leads the authors to hypothesize that whereas BME had been released from the ribs broken during the CPR the FE could have been derived from the subcutaneous tissue. In our patient, the remarkable amount of blood cells precursors obstructing the brain small vessels must be ascribed to their abundance in the bone marrow of a young subject as compared to that present in elderly patients observed by other investigators [10, 11] in whom the hemopoietic tissue is largely replaced by fat .
The occurrence of a trauma-associated full-blown FES represents a potentially catastrophic clinical condition whose diagnosis requires a high index of suspicion. Its severity largely depends on the extension of trauma and on the amount of BE and BME consequently released. The only risk-reducing measure is the early fixation avoiding the medullary reaming and the treatment is only supportive.
Conflicts of Interest
The authors declare that they have no conflicts of interest.
- K. Newbigin, C. A. Souza, C. Torres et al., “Fat embolism syndrome: State-of-the-art review focused on pulmonary imaging findings,” Respiratory Medicine, 2015.
- P. D. Stein, A. Y. Yaekoub, F. Matta, and M. Kleerekoper, “Fat embolism syndrome,” The American Journal of the Medical Sciences, vol. 336, no. 6, pp. 472–477, 2008.
- R. Gangaraju, V. V. B. Reddy, and M. B. Marques, “Fat embolism syndrome secondary to bone marrow necrosis in patients with hemoglobinopathies,” Southern Medical Journal, vol. 109, no. 9, pp. 549–553, 2016.
- S. Akhtar, “Fat Embolism,” Anesthesiology Clinics, vol. 27, no. 3, pp. 533–550, 2009.
- E. E. Husebye, T. Lyberg, and O. Røise, “Bone marrow fat in the circulation: clinical entities and pathophysiological mechanisms,” Injury, vol. 37, no. 4, p. -S18, 2006.
- T. J. Blokhuis, H. Pape, and J. Frölke, “Timing of definitive fixation of major long bone fractures: Can fat embolism syndrome be prevented?” Injury, vol. 48, Supplement 1, pp. S3–S6, 2017.
- N. Shaikh, “Emergency management of fat embolism syndrome,” Journal of Emergencies, Trauma, and Shock, vol. 2, no. 1, pp. 29–33, 2009.
- B. Lindeque, H. Schoeman, G. Dommisse, M. Boeyens, and A. Vlok, “Fat embolism and the fat embolism syndrome. A double-blind therapeutic study,” The Journal of Bone & Joint Surgery, vol. 69, no. 1, pp. 128–131, 1987.
- S. A. Schonfeld, Y. Ploysongsang, R. DiLisio et al., “Fat embolism prophylaxis with corticosteroids. A prospective study in high-risk patients,” Annals of Internal Medicine, vol. 99, no. 4, pp. 438–443, 1983.
- M. S. Dettmer, N. Willi, T. Thiesler, P. Ochsner, and G. Cathomas, “The impact of pulmonary bone component embolism: An autopsy study,” Journal of Clinical Pathology, vol. 67, no. 4, pp. 370–374, 2014.
- E. A. Eriksson, D. C. Pellegrini, W. E. Vanderkolk, C. T. Minshall, S. M. Fakhry, and S. D. Cohle, “Incidence of pulmonary fat embolism at autopsy: An undiagnosed epidemic,” Journal of Trauma - Injury Infection and Critical Care, vol. 71, no. 2, pp. 312–315, 2011.
- E. A. Eriksson, “Fat embolism in pediatric patients: an autopsy evaluation of incidence and etiology,” Journal of Critical Care, vol. 30, no. 1, pp. 221–e1, 2015.
- D. A. Godoy, M. Di Napoli, and A. A. Rabinstein, “Cerebral Fat Embolism: Recognition, Complications, and Prognosis,” Neurocritical Care, pp. 1–8, 2017.
- T. J. Blokhuis, H. Pape, and J. Frölke, “Timing of definitive fixation of major long bone fractures: Can fat embolism syndrome be prevented?” Injury, vol. 48, pp. S3–S6, 2017.
- T. White, B. A. Petrisor, and M. Bhandari, “Prevention of fat embolism syndrome,” Injury, vol. 37, no. 4, pp. S59–S67, 2006.
- E. Kamenar and P. C. Burger, “Cerebral fat embolism: A neuropathological study of a microembolic state,” Stroke, vol. 11, no. 5, pp. 477–484, 1980.
- L. Cui, A. Bakreen, F. Nitzche et al., “The cerebral embolism evoked by intra-arterial delivery of allogeneic bone marrow mesechimal stem cell in rats is related to cell dose and infusion velocity,” Stem Cell Research & Therapy, vol. 6, pp. 11–20, 2015.
- J. Jarmer, G. Ampanozi, M. J. Thali, and S. A. Bolliger, “Role of Survival Time and Injury Severity in Fatal Pulmonary Fat Embolism,” The American Journal of Forensic Medicine and Pathology, vol. 38, no. 1, pp. 74–77, 2017.
- R. G. Kellogg, R. B. V. Fontes, and D. K. Lopes, “Massive cerebral involvement in fat embolism syndrome and intracranial pressure management,” Journal of Neurosurgery, vol. 119, no. 5, pp. 1263–1270, 2013.
- A. R. Gurd and R. I. Wilson, “The fat embolism syndrome,” The Journal of Bone & Joint Surgery, vol. 56B, no. 3, pp. 408–416, 1974.
- S. R. Tuljapurkar, T. R. McGuire, S. K. Brusnahan et al., “Changes in human bone marrow fat content associated with changes in hematopoietic stem cell numbers and cytokine levels with aging,” Journal of Anatomy, vol. 219, no. 5, pp. 574–581, 2011.
Copyright © 2018 Giorgio Berlot et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.